Saunders, FACHE, is the president and CEO of Wellstar Health System, one of the largest and most integrated health systems in Georgia
Covering weight loss medications will be a significant expenditure for payers on the pharmacy benefit but could potentially result in long-term savings. Arguments against coverage aside from the steep cost include the lack of historical data on efficacy and reports of gastrointestinal disturbances such as constipation, diarrhea, nausea, vomiting and severe abdominal pain
This innovative smart hydrogel is an ideal candidate for clinical application and translational research [191]
Who Should Not Start This Stack Because CJC-1295 Ipamorelin stimulates growth hormone, patients with active malignancy, a personal history of certain cancers, pregnancy, breastfeeding, uncontrolled diabetes, or significant pituitary disease are generally not candidates
In adults with obesity or overweight who have not achieved adequate results from lifestyle changes (like a reduced-calorie diet and increased physical activity) alone, the American Gastroenterological Association (AGA) recommends adding medication to the lifestyle changes rather than continuing with lifestyle modifications alone
Appetite suppression typically begins around week 3-4, with most users noticing they feel satisfied with smaller portions and experience fewer cravings between meals